Published in Mem Inst Oswaldo Cruz on February 13, 2015
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
Pathogenesis of liver fibrosis. Annu Rev Pathol (2011) 5.27
Banff schema for grading liver allograft rejection: an international consensus document. Hepatology (1997) 3.22
Complement and its role in innate and adaptive immune responses. Cell Res (2009) 3.07
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat Genet (2005) 2.20
Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis. Liver Transpl (2011) 2.10
The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant (2011) 1.98
C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant (2006) 1.62
Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant (2006) 1.50
Natural history of recurrent hepatitis C. Liver Transpl (2002) 1.49
C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant (2006) 1.40
Effects of formalin fixation and prolonged block storage on detection of hepatitis C virus RNA in liver tissue. Diagn Mol Pathol (1997) 1.17
Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology (2009) 1.16
Evolution of hepatitis C virus in liver allografts. Liver Transpl (2009) 1.13
Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients. J Clin Microbiol (2011) 1.11
Humoral rejection of human organ transplants. Springer Semin Immunopathol (2003) 1.10
Transcriptional repression of C4 complement by hepatitis C virus proteins. J Virol (2011) 1.04
Risk factors for hepatitis C recurrence after liver transplantation. J Viral Hepat (2007) 1.04
Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies. Liver Transpl (2011) 0.98
Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol (2007) 0.96
Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts. Liver Transpl (2012) 0.92
Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl (2004) 0.91
C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology (2007) 0.91
Phenotypes of antibody-mediated rejection in organ transplants. Transpl Int (2012) 0.90
Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry. Protein Cell (2010) 0.90
Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl (2006) 0.89
Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl (2002) 0.89
Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring? Am J Transplant (2011) 0.88
Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant (2005) 0.88
An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases. Hum Pathol (2008) 0.87
Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation (2004) 0.87
Immunostaining for membrane attack complex of complement is related to cell necrosis in fulminant and acute hepatitis. Gastroenterology (1995) 0.86
C4d: a marker for hepatic transplant rejection. Transplant Proc (2006) 0.85
Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options. J Clin Gastroenterol (2003) 0.84
Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection. Virchows Arch (2005) 0.82
Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection. J Med Virol (1998) 0.82
Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts. Am J Transplant (2013) 0.82
Cold activation of serum complement in patients with chronic hepatitis C: study on activating pathway and involvement of IgG. Acta Med Okayama (2001) 0.81
Significance of C4d deposition in the diagnosis of rejection after liver transplantation. Transplant Proc (2006) 0.80
Complement C4d immunohistochemistry in the assessment of liver allograft biopsy samples: applications and pitfalls. Liver Transpl (2011) 0.80
Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants. Mod Pathol (1999) 0.80
In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease. Transplantation (1998) 0.80
ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence? Transpl Immunol (2010) 0.80
Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation. Liver Transpl (2008) 0.80
Correlation of histology, viral load, and in situ viral detection in hepatic biopsies from patients with liver transplants secondary to hepatitis C infection. Hum Pathol (2002) 0.79
Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone. Clin Transplant (2003) 0.79
Antibody-mediated rejection in the liver allograft. Curr Opin Organ Transplant (2012) 0.79
The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C. Liver Transpl (2001) 0.78
The value of C4d deposit in post liver transplant liver biopsies. Transpl Immunol (2012) 0.77
Humoral immunity in acute cellular rejection after living-donor liver transplantation. Transplant Proc (1999) 0.76